Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Xtant Medical Holdings, Inc. publishes a filing, an earnings call transcript or a press release.

Get XTNT alerts

About Scott Neils

Scott Neils is recorded as CFO at Xtant Medical Holdings, Inc. (XTNT). The proxy statement of Xtant Medical Holdings, Inc. reports total compensation of $939,369 for Scott Neils in fiscal 2025, including a base salary of $416,000. Disclosed compensation is on record for 4 fiscal years. Scott Neils has spoken on 14 earnings calls across 1 company, most recently for Xtant Medical Holdings, Inc. on August 11, 2026. Xtant Medical Holdings, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Xtant Medical Holdings, Inc. includes Sean Browne (CEO and Board Member), Sean E. Browne (CEO and Board Member), Stavros G. Vizirgianakis (Chairman) and 7 others.

Scott Neils on recent calls

“Total revenue for the second quarter of 2026 was $23 million, compared to $35.4 million for the second quarter of 2025, or $24.8 million for the second quarter of 2025, on a pro forma basis, excluding the revenue from the non-core products and businesses that we sold to Companion Spine and non-recurring license…”
CFO, Xtant Medical Holdings, Inc. Q2 FY2026 Earnings Call ·
“I'll start first with our financial results and then conclude by sharing some specific amounts related to our recent divestitures and license revenue for the benefit of looking ahead to 2026.”
CFO, Xtant Medical Holdings, Inc. Q4 FY2025 Earnings Call ·
“Total revenue for the third quarter of 2025 was $33.3 million compared to $27.9 million for the same period in 2024.”
CFO, Xtant Medical Holdings, Inc. Q3 FY2025 Earnings Call ·
“Total revenue for the second quarter of 2025 was $35.4 million, compared to $29.9 million for the same period in 2024.”
CFO, Xtant Medical Holdings, Inc. Q2 FY2025 Earnings Call ·
“Total revenue for the first quarter of 2025 was $32.9 million, compared to $27.9 million for the same period in 2024. The 18% increase is attributed primarily to year-over-year growth in our biologics product family, exclusive of the impact of $3.6 million of licensing revenue during the first quarter of 2025.”
CFO, Xtant Medical Holdings, Inc. Q1 FY2025 Earnings Call ·

Affiliation history

Company network

Leadership on record at Xtant Medical Holdings, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Xtant Medical Holdings, Inc. (XTNT) $416,000 $939,369
2024 Xtant Medical Holdings, Inc. (XTNT) $411,692 $883,507
2023 Xtant Medical Holdings, Inc. (XTNT) $400,000 $937,853
2022 Xtant Medical Holdings, Inc. (XTNT) $366,977 $766,533

Recent activity

Show 2 earlier activities